This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Schrodinger, LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Leah Frye: Innovator in Cancer Treatment
Introduction
Leah Frye is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds.
Latest Patents
Leah Frye holds a patent for "Heterocyclic pericondensed CDC7 kinase inhibitors for the treatment of cancer." This patent describes compounds of Formula (I) and their pharmaceutically acceptable salts. The application also details pharmaceutical compositions that include these compounds and methods for using them to inhibit kinase activity and treat cancer.
Career Highlights
Leah Frye is currently employed at Schrödinger, LLC, where she continues to advance her research in the pharmaceutical sciences. Her work focuses on developing effective treatments for cancer, showcasing her dedication to improving patient outcomes.
Collaborations
Leah collaborates with Xianhai Huang, contributing to the innovative environment at Schrödinger, LLC. Their combined expertise enhances the research efforts aimed at discovering new therapeutic options.
Conclusion
Leah Frye's contributions to cancer treatment through her patent and work at Schrödinger, LLC highlight her role as a leading inventor in the pharmaceutical industry. Her innovative spirit and dedication to research continue to pave the way for advancements in cancer therapies.